Skip to content

Anglopharma

Active
Private limited companyfounded 1968active for 58 yearsZeelaan 126, 8660 De Panne, BelgiumKBO/BCE: BE 0406.061.794
Summary

Anglopharma has been active since 1968 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €504,483 and a net result of €15,526. Equity has been stable since 2019 (±2.5% per year). Its solvency ranks better than 89% of 612 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730and 1 other
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 31-01-2026
Establishment unit
2.000.341.918 8660 De Panne, since 01-09-1965
Financial year end
31 January
Peppol
Reachable since 23-10-2025

Board and ownership

Board
  • Trypsteen KrisDirector

Financial position

95 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 31-01-2026
Gross margin
€176,237
▼ 14.0%
Turnover
≈ €820,000
estimated
Profit
€15,526
Equity
€504,483
▼ 1.3%
Total assets
€669,817
▲ 4.0%
Employees on 31-01-2026
2
=
Filed on 03-06-2026, 89 days before the deadline
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 3.45, cash €223,629Founded in 1968Equity €504,483 (75.3% of total assets)Show the evidence

Checked score

Score 2026
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 64% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2025
Strong
Solvency 100=
equity 75.3% of total assets
Liquidity 83-1
short-term debt 24.4% · cash 33.4%
Profitability 57+54
return on assets 2.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.2%▲ +0.1 percentage points vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026highest value 07-2026: < 0.1%▼ -0.2 percentage points vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €45,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.45 (4.05 in 2025), above the usual 1.5. Short-term debt is 24.4% and cash 33.4% of total assets. 24.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 86% on liquidity, 41% on profitability and 36% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 3.45, cash €223,629
NBB · annual accounts
lowers risk · Founded in 1968
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €504,483 (75.3% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-01-2026 was due by 31-08-2026 and was filed on 03-06-2026, 89 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
89 days early
2025
22 days late
2024
25 days late
2023
29 days late
2022
22 days late
2021
28 days late
2020
60 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 14 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-01-2027 and is due by 31-08-2027. Nothing is late today. The company usually files around 22 September (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-01-2027 year end31-08-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Back in profit in 2026after a loss of €83,090 in 2025 €15,526 View
  • Positive: Higher solvency than 88% of companies in retail tradesector median 32.7% · 612 companies 75.3% View

Comparable companies

These companies have the same main activity as Anglopharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €561,000 and €697,000, founded between 1971 and 1982.

CompanyTotal assetsGross margin
Anglopharma De Panne€669,817€176,237
APOTHEEK VAN WYNSBERGHE Waregem€609,970€195,361
Apotheek Grillet Moorslede€694,883€233,157
PHARMACIE BRENARD Rebecq€615,443€151,981
PHARMACIE CRAHAY Chaudfontaine€618,494€161,018
APOTHEEK DEBEUCKELAERE Wielsbeke€696,614€220,862
VERSTRAETE JEROEN APOTHEEK Harelbeke€560,565€163,995
Full comparison

Key facts about Anglopharma

What is the company number of Anglopharma?
The company number of Anglopharma is 0406.061.794. The VAT number is the same number with BE in front: BE 0406.061.794.
Where is Anglopharma based?
The registered office is at Zeelaan 126, 8660 De Panne.Company details
What does Anglopharma do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Anglopharma?
The legal form of Anglopharma is Private limited company (BV).
When was Anglopharma founded?
Anglopharma was founded on 01-01-1968.
Is Anglopharma still active?
Yes, Anglopharma is an active enterprise in the KBO register.
How many employees does Anglopharma have?
Anglopharma had an average of 1.4 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
Which joint committee does Anglopharma fall under?
In its 31-01-2026 annual accounts, Anglopharma states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of Anglopharma?
The turnover in financial year 2026 is ≈ €820,000. This figure is estimated from the gross margin of €176,237 and 51 comparable companies (NACE 477). It probably lies between €560,000 and €1.6m.
Is Anglopharma profitable?
In financial year 2026, Anglopharma made a profit of €15,526.
Where can I find the annual accounts of Anglopharma?
Anglopharma filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of Anglopharma due?
Anglopharma must file the annual accounts for financial year 2027 by 31-08-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.